Nancy Thornberry insider trades

Open-market stock purchases and sales by Nancy Thornberry, Director at Denali Therapeutics Inc, from SEC Form 4 filings since Feb 10, 2020.

Recent trades

DateStockTradeValue
Sep 2, 2026DNLI Denali Therapeutics IncSold$247K
Sep 2, 2026DNLI Denali Therapeutics IncSold$14.6K
Jun 22, 2026SDGR Schrodinger, IncBought (not open market)—
Jun 22, 2026SDGR Schrodinger, IncBought (not open market)—
Jun 3, 2026DNLI Denali Therapeutics IncBought (not open market)—
Jun 3, 2026DNLI Denali Therapeutics IncBought (not open market)—
May 1, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
May 1, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)—
May 1, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
May 1, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—

Companies traded

  • DNLI Denali Therapeutics Inc: 2 sales, last Sep 2, 2026
  • SDGR Schrodinger, Inc: 2 sales, last Jun 22, 2026
  • VRTX Vertex Pharmaceuticals Inc / MA: other filings, last May 1, 2026

Get free alerts when Nancy Thornberry files a new trade →